Oct 16, 2026 · 49 min
Soul Patts turns patient capital into an Australian compounding machine
Soul Patts: The $18bn ASX Giant Most Australians Have Never Heard Of
The episode tests whether Soul Patts’s exceptional history and durable portfolio justify its premium valuation amid succession and management risks.
- 1Permanent capital let Soul Patts compound through pharmacies, bricks, coal, media and telecommunications without forced selling.
- 2Its long-term record reflects patient ownership and management quality, but the current premium leaves less room for error.
- 3The panel sees an outstanding business, yet prefers a lower entry price as succession and scale complicate the investment case.
Don't miss
The panel’s final verdict captures the episode’s tension: Soul Patts is a remarkable business, but its premium valuation makes a lower entry price more appealing.
The brief
Adam Schwab and Adir Shiffman join Scott Middleton to examine how Washington H. Soul Pattinson evolved from a pharmacy business into an $18 billion investment conglomerate.
The company’s permanent capital supported decades-long bets on Brickworks, New Hope, NBN and TPG, turning unfashionable assets into major sources of wealth.
Soul Patts resembles Berkshire in its patience and diversification, but the panel argues that much of its advantage may reside in exceptional management rather than structural protection.
The central tension is valuation: Soul Patts remains an exceptional business, yet its premium to net asset value and coming leadership transition make patience attractive for prospective buyers.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.